HollisterStier inks pact with Prism Pharma on cardiovascular drug PM101
BY OUR PHARMA CORRESPONDENT
March 6, 2006
Sterile injectable products maker HollisterStier Contract Manufacturing has signed a Letter of Intent with Prism
Pharmaceuticals, Inc. to develop a process for compounding and fill/finishing Prism's PM101, an acute care cardiovascular
HollisterStier is producing PM101 registration material for clinical trials and is supporting Prism Pharmaceuticals filing of a
New Drug Application (NDA). PM101 will be filled into vials and syringes.
HollisterStier is a contract manufacture of quality sterile injectables for the global pharmaceutical and biopharmaceutical
market. Based in Spokane, Washington, the company is committed to meeting customer expectations in all aspects of our
business from quality manufacturing to regulatory support.
Based in King of Prussia, Pennsylvania, Prism Pharmaceuticals, Inc. is a specialty pharmaceutical company developing and
commercializing acute care cardiovascular products.